Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Group Design02:01

Group Design

9.6K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
9.6K
Blinding01:11

Blinding

2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

5.9K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
5.9K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.5K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of two commonly used methods of weight estimation.

Archives of disease in childhood·2003
Same author

Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries.

Journal of epidemiology and community health·2003
Same author

Retained foreign bodies in the vagina.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2003
Same author

Comparison of peripheral and central venous pressures in critically Ill patients.

Anaesthesia and intensive care·2003
Same author

Random errors in the measurement of 10 cardiovascular risk factors.

European journal of epidemiology·2002
Same author

Effect of aged garlic extract on caspase-3 activity, in vitro.

Nutritional neuroscience·2002
Same journal

Effectiveness of clinical trial recruitment strategies in a safety-net hospital.

Contemporary clinical trials·2026
Same journal

Are older adult research participants representative of the general population? Results from 19 clinical studies at one academic research center.

Contemporary clinical trials·2026
Same journal

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD Caregiver Oncology Needs Evaluation Tool (CONNECT) trial.

Contemporary clinical trials·2026
Same journal

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026
Same journal

Evaluating clinical outcomes of using Undermyfork mobile app with Dexcom G7: Protocol for CGM-Undermyfork randomized controlled trial.

Contemporary clinical trials·2026
Same journal

Outcomes of dyadic recruitment in the promoting re-engagement in meaningful activity (PRIMA) trial.

Contemporary clinical trials·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Unequal allocation in randomised phase II trials.

R Jackson1, T Cox1

  • 1Department of Health Data Science, Block F, Waterhouse Building, University of Liverpool, L69 3GL.

Contemporary Clinical Trials
|August 7, 2025
PubMed
Summary
This summary is machine-generated.

Unequal patient allocation in phase II clinical trials can reduce sample size requirements compared to equal allocation. This optimization is particularly effective when response rates differ significantly between treatment groups.

Keywords:
Phase IIRandomisedSample sizeUnequal allocation

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Equal patient allocation is standard in randomized clinical trials, presumed to optimize resource use.
  • Phase II study designs often use binary endpoints and odds ratios for efficacy assessment.
  • Equal allocation provides optimal precision for odds ratios only when response rates are similar, a scenario of limited clinical interest.

Purpose of the Study:

  • To derive optimal allocation proportions for clinical trials to maximize precision of the odds ratio.
  • To compare sample size requirements of unequal allocation versus equal allocation in phase II studies.

Main Methods:

  • Developed allocation proportions to maximize odds ratio precision when response rate differences are anticipated.
  • Performed sample size calculations comparing unequal and equal allocation designs.
  • Utilized exact methods based on Jung and Sargent for sample size calculations.

Main Results:

  • Unequal allocation resulted in smaller required sample sizes compared to equal allocation, maintaining the same Type I error rate and power.
  • The sample size savings increased as the control group's response rate approached 0 or 1, with a fixed relative treatment effect.
  • This demonstrates a significant efficiency gain through unequal allocation under specific conditions.

Conclusions:

  • Clinical trialists designing phase II studies should consider unequal patient allocation.
  • Unequal allocation offers potential for substantial sample size savings.
  • Adopting unequal allocation can lead to more efficient use of resources in clinical trials.